ArticlePeerJ2025
Clinical, molecular, and resistance features of
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Risk factors and outcomes of emerging Listeria monocytogenes infection in Pakistan: Insights from a tertiary care hospital.PloS one · 2026Article
- Virulence Gene Profiling and Molecular Typing of Clinical Isolates ofInfection and drug resistance · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Listeriosis, caused by Methods: This study included non-perinatal patients with listeriosis from four tertiary centers in Shandong, China. Data on demographics, clinical characteristics, and outcomes were collected retrospectively over 8 years (2015-2022). Results: Among 292,254 non-perinatal patients, 27 listeriosis cases were identified, resulting in an incidence of nine cases per 100,000 admissions. Patients had a median age of 56 years, with 66.7% having comorbidities. Fever was the most common symptom (88.9%), and 44.4% had central nervous system involvement. Most patients (26/24; 96.3%) received antibiotics, 37.0% received monotherapy and 59.3% combination therapy. The mortality rate was 22.2%. The antimicrobial susceptibility test showed that 25 strains were sensitive to most antibiotics. Multilocus sequence typing revealed nine sequence types (ST), predominantly ST8 (44.4%), and serogroup 1/2a is the most common serogroup (66.7%). Conclusions: This study provides valuable insights into the clinical and molecular features of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.